- 1
- 2
- project . 2017 - 2022Funder: EC Project Code: 731623Overall Budget: 6,000,000 EURFunder Contribution: 6,000,000 EUROpen Access mandate for PublicationsPartners: INC RESEARCH UK LTD, KUL, TTOP, GRANZER REGULATORY CONSULTING & SERVICES, ISA, ECPC
Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standard of care in all European countries, and where approved it is not sufficiently adopted. Once infected, these vaccines no longer p...
- project . 2015 - 2019Funder: EC Project Code: 634893Overall Budget: 5,834,340 EURFunder Contribution: 5,834,340 EUROpen Access mandate for PublicationsPartners: UCLH, UCL, Eli Lilly and Company Limited, TTOP, AUDION, NKUA, LINICAL NETHERLANDS B.V., UT, NORDIC BIOSCIENCE CLINICAL DEVELOPMENT
Hearing loss is a chronic non-communicable disease disabling over 328 million adults, and 32 million children worldwide. Sensorineural hearing loss due to loss of auditory hair cells was long thought to be irreversible. However, recent animal studies have demonstrated t...
- project . 2017 - 2019Funder: EC Project Code: 733266Overall Budget: 1,999,620 EURFunder Contribution: 1,999,620 EUROpen Access mandate for PublicationsPartners: VIS, EUROPROJECT EP, PNO ADVIESGROEP, INNEEN, Karolinska Institutet Innovations (Sweden), TTOP, TTS, Senvion SE (Germany), CIAOTECH, EU...
A recent evaluation of FP7 projects executed by the EC, showed that an estimated 80% of funded Health projects lacks valorisation. The “UTILE” proposal presents the EU-Health Innovation Marketplace, an online tool to better valorise the FP7 Health and Horizon2020 SC1 pr...
- project . 2016 - 2021Funder: EC Project Code: 686089Overall Budget: 8,291,220 EURFunder Contribution: 8,291,220 EUROpen Access mandate for PublicationsPartners: Evonik Nutrition & Care GmbH, IOX, EVONIK CREAVIS GMBH, SPECIALIZED MEDICAL SERVICES-ONCOLOGY BV, ONCOARENDI THERAPEUTICS SP. Z O.O., IMC ASCR INSTITUTE OF MACROMOLECULAR CHEMISTRY OF THE ASCR VVI, INT, STICHTING KATHOLIEKE UNIVERSITEIT, UOXF, TTOP...
PRECIOUS aims at scaling-up biodegradable nanomedicines for multimodal precision cancer immunotherapy. With 3.5 million cancer patients in Europe every year, new cancer medicines are eagerly awaited, notably for prostate and ovarian cancer. Systemically applied new immu...
- project . 2020 - 2025Funder: EC Project Code: 874807Overall Budget: 9,526,100 EURFunder Contribution: 9,526,100 EUROpen Access mandate for PublicationsPartners: BOWEL RESEARCH UK, QMUL, TTOP, AUH, UCL, AU, IST, IIS-FJD, Centre Hospitalier Universitaire De Rouen, Medical University of Graz...
Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affected individuals and their families. Women with FI arising from childbirth injury may benefit from regenerative medicine using autol...
- 1
- 2
Powered by OpenAIRE Research Graph